SERA PROGNOSTICS, INC. Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
SERA PROGNOSTICS, INC. (SERA) reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of $171.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2026-08-12
- SERA PROGNOSTICS, INC. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-06-30 was $287.00K, a 29.14% decline year-over-year.
- SERA PROGNOSTICS, INC. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-03-31 was -$116.00K.
- SERA PROGNOSTICS, INC. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-12-31 was $753.00K.
- SERA PROGNOSTICS, INC. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-09-30 was $16.00K.
- SERA PROGNOSTICS, INC. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2025 was $682.00K.
- SERA PROGNOSTICS, INC. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2024 was -$575.00K.
- SERA PROGNOSTICS, INC. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2023 was -$2.30M.
- SERA PROGNOSTICS, INC. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2022 was -$514.00K, a 137.03% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $287.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $171.00K 10-Q · filed 2026-08-12 | $924.00K derived: sum of 3 quarters · filed 2026-08-12 | $940.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | -$116.00K 10-Q · filed 2026-05-06 | $637.00K derived: sum of 2 quarters · filed 2026-05-06 | $653.00K derived: sum of 3 quarters · filed 2026-05-06 | $1.06M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $753.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $769.00K derived: sum of 2 quarters · filed 2026-03-18 | $1.17M derived: sum of 3 quarters · filed 2026-08-12 | $682.00K 10-K · filed 2026-03-18 |
| 2025-09-30 | $16.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $421.00K derived: sum of 2 quarters · filed 2026-08-12 | -$71.00K 10-Q · filed 2025-11-13 | -$124.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $405.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$87.00K 10-Q · filed 2026-08-12 | -$140.00K derived: sum of 3 quarters · filed 2026-08-12 | -$806.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | -$492.00K 10-Q · filed 2026-05-06 | -$545.00K derived: sum of 2 quarters · filed 2026-05-06 | -$1.21M derived: sum of 3 quarters · filed 2026-05-06 | -$1.05M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | -$53.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | -$719.00K derived: sum of 2 quarters · filed 2026-03-18 | -$561.00K derived: sum of 3 quarters · filed 2026-03-18 | -$575.00K 10-K · filed 2026-03-18 |
| 2024-09-30 | -$666.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$508.00K derived: sum of 2 quarters · filed 2025-11-13 | -$522.00K 10-Q · filed 2025-11-13 | -$840.00K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $158.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $144.00K 10-Q · filed 2025-08-06 | -$174.00K derived: sum of 3 quarters · filed 2025-08-06 | -$873.00K derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | -$14.00K 10-Q · filed 2025-05-07 | -$332.00K derived: sum of 2 quarters · filed 2025-05-07 | -$1.03M derived: sum of 3 quarters · filed 2025-05-07 | -$422.00K derived: sum of 4 quarters · filed 2025-05-07 |
| 2023-12-31 | -$318.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19 | -$1.02M derived: sum of 2 quarters · filed 2025-03-19 | -$408.00K derived: sum of 3 quarters · filed 2025-03-19 | -$2.30M 10-K · filed 2025-03-19 |
| 2023-09-30 | -$699.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$90.00K derived: sum of 2 quarters · filed 2024-11-06 | -$1.98M 10-Q · filed 2024-11-06 | -$1.96M derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $609.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$1.28M 10-Q · filed 2024-08-07 | -$1.26M derived: sum of 3 quarters · filed 2024-08-07 | -$282.00K derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | -$1.89M 10-Q · filed 2024-05-08 | -$1.87M derived: sum of 2 quarters · filed 2024-05-08 | -$891.00K derived: sum of 3 quarters · filed 2024-05-08 | -$465.00K derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | $1.00M derived: sum of 2 quarters · filed 2024-03-20 | $1.43M derived: sum of 3 quarters · filed 2024-03-20 | -$514.00K 10-K · filed 2024-03-20 |
| 2022-09-30 | $982.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $1.41M derived: sum of 2 quarters · filed 2023-11-08 | -$534.00K 10-Q · filed 2023-11-08 | $1.22M derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $426.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$1.52M 10-Q · filed 2023-08-09 | $237.00K derived: sum of 3 quarters · filed 2023-08-09 | $807.00K derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | -$1.94M 10-Q · filed 2023-05-10 | -$189.00K derived: sum of 2 quarters · filed 2023-05-10 | $381.00K derived: sum of 3 quarters · filed 2023-05-10 | $743.00K derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $1.75M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $2.32M derived: sum of 2 quarters · filed 2023-03-22 | $2.69M derived: sum of 3 quarters · filed 2023-03-22 | $1.39M 10-K · filed 2023-03-22 |
| 2021-09-30 | $570.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $932.00K derived: sum of 2 quarters · filed 2022-11-09 | -$365.00K 10-Q · filed 2022-11-09 | $84.00K derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $362.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | -$935.00K 10-Q · filed 2022-08-10 | -$486.00K derived: sum of 3 quarters · filed 2022-08-10 | -$280.00K derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | -$1.30M 10-Q · filed 2022-05-10 | -$848.00K derived: sum of 2 quarters · filed 2022-05-10 | -$642.00K derived: sum of 3 quarters · filed 2022-05-10 | |
| 2020-12-31 | $449.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $655.00K derived: sum of 2 quarters · filed 2022-03-29 | $174.00K 10-K · filed 2022-03-29 | |
| 2020-09-30 | $206.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$275.00K 10-Q · filed 2021-11-09 | ||
| 2020-06-30 | -$481.00K 10-Q · filed 2021-08-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |